Gordon Haskett Upgrades Emerson (EMR) to Buy (1)
Gordon Haskett analyst John Inch upgraded Emerson (NYSE: EMR) from Hold (3) to Buy (1) with a price target of $104.00.
Shares of Emerson closed at $82.75 yesterday.
You May Also Be Interested In
- Credit Suisse Upgrades Transurban Group (TCL:AU) (TRAUF) to Outperform
- Jefferies Upgrades Svenska Cellulosa Aktiebolaget SCA (SCAB:SS) (SVCBF) to Buy
- Compass Point Upgrades TriplePoint Venture Growth (TPVG) to Buy
Create E-mail Alert Related CategoriesUpgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!